This event seeks to update researchers and professionals on recent clinical trials, immunotherapy, and translating antibodies. Leading researchers will present on topics such as a histone acetyltransferase, DNA methyltransferase inhibitors, translating and combining antibodies, and many more. In addition to scientific talks, dedicated networking sessions will allow attendees to better dialogue on epigenetic modification and transcriptional regulation, updates on clinical trials of epigenetic drugs, and novel therapeutic targets.